These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27575927)

  • 41. Vascular calcifications in chronic kidney disease--clinical management.
    Checheriţă IA; Smarandache D; David C; Ciocâlteu A; Ion DA; Lascăr I
    Rom J Morphol Embryol; 2012; 53(1):7-13. PubMed ID: 22395493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers of bone and mineral disorders (FGF-23, fetuin-A) and vascular calcification scores as predictive tools for cardiovascular death in dialysis patients, at 10 years of follow-up.
    Fernández P; Douthat W; Castellano M; Cardozo G; Garay G; de Arteaga J; Chiurchiu C; de la Fuente J
    Medicina (B Aires); 2021; 81(2):191-197. PubMed ID: 33906137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
    Hutcheson JD; Goettsch C
    Circ Res; 2023 Apr; 132(8):993-1012. PubMed ID: 37053279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
    Matsumoto T; Fukushima S; Kanasaki T; Hagino S
    Biol Trace Elem Res; 2012 Dec; 150(1-3):278-84. PubMed ID: 22700181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities.
    Himmelsbach A; Ciliox C; Goettsch C
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32183352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mineral and bone disorder and vascular calcification in patients with chronic kidney disease.
    Peres LA; Pércio PP
    J Bras Nefrol; 2014; 36(2):201-7. PubMed ID: 25055361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenesis and treatment of vascular calcification in CKD].
    Brancaccio D; Gallieni M; Pasho S; Fallabrino G; Olivi L; Volpi E; Ciceri P; Missaglia E; Ronga C; Brambilla C; Butti A; Rocca-Rey L; Chiarelli G; Cozzolino M
    G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jul; 17(10):1363-73. PubMed ID: 27156578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bone mineral metabolism in patients with chronic kidney disease: review of its pathophysiology and morbimortality].
    Bernuy J; Gonzales GF
    Rev Peru Med Exp Salud Publica; 2015; 32(2):326-34. PubMed ID: 26338395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
    Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
    J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.
    Zeng C; Guo C; Cai J; Tang C; Dong Z
    Diab Vasc Dis Res; 2018 Mar; 15(2):99-105. PubMed ID: 29168393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of abdominal aortic calcification at different stages of chronic kidney disease.
    Biyik Z; Selcuk NY; Tonbul HZ; Anil M; Uyar M
    Int Urol Nephrol; 2016 Dec; 48(12):2061-2068. PubMed ID: 27620901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
    Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
    Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs Are Associated with Uremic Toxicity, Cardiovascular Calcification, and Disease.
    Massy ZA; Metzinger-Le Meuth V; Metzinger L
    Contrib Nephrol; 2017; 189():160-168. PubMed ID: 27951581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [[GUIDELINES FOR THE PREVENTION, MONITORING AND THERAPY OF CHRONIC KIDNEY DISEASE-METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE].].
    Bašić-Jukić N; Pavlović D; Šmalcelj R; Tomić-Brzac H; Orlic L; Radić J; Vujičić B; Lovčić V; Pavić E; Klarić D; Gulin M; Spasovski G; Ljutić D; Danic D; Prgomet D; Resić H; Ratković M; Kes P; Raćki S
    Lijec Vjesn; 2016 May; 138(5-6):107-120. PubMed ID: 29182822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease.
    Shah A
    Panminerva Med; 2017 Jun; 59(2):124-132. PubMed ID: 28290186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
    de Oliveira RB; Louvet L; Riser BL; Barreto FC; Benchitrit J; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Massy ZA
    Calcif Tissue Int; 2015 Aug; 97(2):179-92. PubMed ID: 26087714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of mineral and bone disorders in the development and progression of cardiac and renal pathology in patients with type 1 diabetes mellitus of long duration.
    Biragova MS; Gracheva SA; Glazunova AM; Martynov SA; Ulaynova IN; Ilyin AV; Philippov YI; Musaeva GM; Shamkhalova MS; Shestakova MV
    Diabetes Res Clin Pract; 2016 Aug; 118():29-37. PubMed ID: 27240104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease.
    Lee MJ; Park JT; Park KS; Kwon YE; Han SH; Kang SW; Choi KH; Oh KH; Park SK; Chae DW; Lee K; Hwang YH; Kim SW; Kim YH; Kang SW; Lee J; Ahn C; Yoo TH
    Kidney Int; 2016 Dec; 90(6):1368-1376. PubMed ID: 27884313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D and vascular calcification in chronic kidney disease.
    Rodriguez M; Martinez-Moreno JM; Rodríguez-Ortiz ME; Muñoz-Castañeda JR; Almaden Y
    Kidney Blood Press Res; 2011; 34(4):261-8. PubMed ID: 21691129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.